A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 25 mg and MET XR 1,000 mg) in Healthy Volunteers
NCT05363384
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
CT-L01
DRUG:
Alogliptin Benzoate 25 mg
DRUG:
Metformin HCl XR 1,000 mg
Sponsor
Celltrion